| Document |
Document Title |
|
WO/2012/060120 |
The purpose of the present invention is to provide a novel protein that shows specific localization in fat droplets. The present invention provides: (A) a protein in which the N-terminus of a polypeptide (b), which comprises the amino ac...
|
|
WO/2012/061372 |
The present invention is directed to a method for preparing renewable and relatively high purity p-xylene from biomass, and from C5 molecules in particular. For example, biomass treated to provide a fermentation feedstock is fermented wi...
|
|
WO/2012/060489 |
The present invention relates to a recombinant microorganism containing a Cornebacterium induced novel indole oxygenase gene, and a method for preparing indirubin using same, and more particularly, to a method for preparing an indigoid c...
|
|
WO/2012/061653 |
Provided herein are metabolically modified microorganisms characterized by having an increased keto-acid flux when compared with the wild-type organism and comprising at least one polynucleotide encoding an enzyme that when expressed res...
|
|
WO/2012/060579 |
The present invention relates to a dead lactobacillus biomass for antimicrobial use; the biomass being produced by subjecting a lactobacillus fermentation liquid to tyndallisation and then separating the same into a fermentation filtrate...
|
|
WO/2012/061382 |
The present invention provides improved fungal strains. In some embodiments, the improved fungal strains find use in hydrolyzing cellulosic material to glucose. The present invention also provides a fungal cell that has been genetically ...
|
|
WO/2012/061629 |
Various embodiments of the present invention are directed toward a method for preparing probiotic nanopartieles from natural sources, comprising performing a biological preparation phase such as isolating any cells derived from either pr...
|
|
WO/2012/058814 |
The present invention clones the second RNA recognition motif (RRM2) gene of FCA-γ gene in Brassica napus, and transforms the RRM2 domain gene into cotton by transgenic method. The transgenic line exhibits characteristics of yield incre...
|
|
WO/2012/058756 |
There are provided methods for producing microalgae that comprise treating a culture medium comprising seawater and nutrients effective for feeding microalgae by means of an ultrafiltration; introducing the treated culture medium into a ...
|
|
WO/2012/060389 |
Provided are: a transformant of yeast of the genus Schizosaccharomyces, which is capable of producing β-glucosidase; and a method for manufacturing the transformant of yeast of the genus Schizosaccharomyces. This transformant of yeast o...
|
|
WO/2012/060666 |
The present invention relates to a method for producing hEGF(human epidermal growth factor) which has the same activity as the wild form, in high concentration and with a high degree of purity. More specifically, the invention relates to...
|
|
WO/2012/060729 |
The invention relates to biotechnology, in particular to strains of microorganisms, and can be used for stimulating immune system activity and increasing animal and human life expectancy. The relic microorganism - a bacteria strain Bacil...
|
|
WO/2012/058919 |
A method for enhancing the rate of acid production of genetically engineered bacteria producing L-phenylalanine is provided, comprising: amplifying the whole phosphoenolpyruvate carboxykinase (pckA) gene by PCR and inserting the amplifie...
|
|
WO/2012/061331 |
The present invention relates to the production of a isoprenoid products from a lignocellulosic feedstock. Specifically at least triple mutant of filamentous fungi having the isoprenoid pathway results in production of isoprenoid product...
|
|
WO/2012/059499 |
The present invention relates to the field of pet food. In particular, the present invention provides pet food compositions comprising non-replicating probiotic micro-organisms. These non-replicating probiotic micro-organisms may be bioa...
|
|
WO/2012/060312 |
The present invention inhibits biofilm formation by Streptococcus mutans and treats tooth decay by using a vegetable lactic acid bacterium belonging to the genus Enterococcus, said vegetable lactic acid bacterium being isolated from rice...
|
|
WO/2012/058835 |
A Bacillus subtilis strain XF-8, deposited as CCTCC No: M2010182, with phosphorus-decomposing ability and a method for producing neutral phytase by using the strain are provided. The method comprises: inoculating the strain into LB mediu...
|
|
WO/2012/060554 |
The present invention relates to a lactobacillus having a multi-coating layer, wherein a lactobacillus is coated with a multi-coating layer comprising a bacterial clump while containing protein, polysaccharide and edible oil/fat componen...
|
|
WO/2012/057396 |
The present invention relates to a yeast expression vector comprising: (a) a sequence homologous to the flanking sequence of a target gene fragment; (b) an expression module comprising (i) a multiple cloning site (MCS), (ii) a promoter o...
|
|
WO/2012/058606 |
The present disclosure identifies methods and compositions for modifying microbial cells, such that the organisms efficiently synthesize terminal olefins, and in particular the use of such organisms for the commercial production of propy...
|
|
WO/2012/055066 |
An Aspergillus strain CICC 2435 and fermentation broth or fermentation broth extract produced by the Aspergillus strain CICC 2435 are provided. The fermentation broth or fermentation broth extract can partially hydrolyze acarbose to prod...
|
|
WO/2012/055998 |
The present invention provides tools and methods for producing organic acids using strains of Monascus which are tolerant to high organic acid concentrations at low pH.
|
|
WO/2012/058630 |
The present invention describes a method to generate new chemical entities (NCEs) that have well-defined activities such as, but not limited to, anti-bacterial, antifungal and anthelmintic effects. The NCEs are generated through adaptive...
|
|
WO/2012/058603 |
The present invention relates to methods of producing n-propanol, isopropanol, and coproducing n-propanol with isopropanol. The present invention also relates to methods for producing propylene, as well as host cells capable of n-propano...
|
|
WO/2012/055997 |
A process for producing polylactic acid (PLA) comprising the steps: fermenting in a fermentation vessel a micro-organism of the genus Monascusin a medium at a pH less than or equal to 5 under conditions which produce lactic acid into the...
|
|
WO/2012/058054 |
The present invention is directed to a composition and method thereof for reducing or eliminating malodors produced by decaying arthropod cadavers comprising an effective amount of one or more entomopathogenic fungi. The invention provid...
|
|
WO/2012/057064 |
The present invention provides: a cellulose gel medium providing good visibility of microbial colonies, which improves on the weaknesses of the cellulose gel media of the prior art; a cellulose gel culture substrate for manufacturing the...
|
|
WO/2012/056187 |
The invention relates to novel strains of microalgae which belong to the Botryococcus genus and which can grow in a mixotrophic mode, as well as to a cultivation method which comprises providing light in the form of flashes for the produ...
|
|
WO/2012/057288 |
The present invention relates to an antibody which has a therapeutic effect on cancer, autoimmune diseases or inflammatory diseases. Namely, the present invention relates to an antibody which exhibits an apoptosis-mediated cytotoxic acti...
|
|
WO/2012/054935 |
There are provided, inter alia, methods for forming (e.g. transgeneration of) hematopoietic stem cells from mesenchymal stem cells.
|
|
WO/2012/053912 |
The invention relates to a method for the provision of silicate to a culture media. In particular the invention relates to a method of mitigating silicate precipitation and/or gel formation when providing silicate to a culture media havi...
|
|
WO/2012/053905 |
The invention relates, inter alia, to novel genetically modified microorganisms capable of using CO to produce 1-butanol and/or a precursor thereof, novel methyltranferases and nucleic acids encoding same, methods for producing genetical...
|
|
WO/2012/054919 |
The present invention relates to the genetic control of parasites and pathogens via the expression of silencing RNA in transgenic plants, including microalgae. In one aspect, the invention exploits the ability of plants to express the si...
|
|
WO/2012/054554 |
Described are compositions and methods relating to the thermostable fungal cellulase enzyme, EGV, and Trichoderma host cells having a modification comprising or consisting essentially of disruption or deletion of nucleotide(s) for expres...
|
|
WO/2012/051207 |
The invention provides methods for treating HIF-1α-overexpressing human tumors, inhibiting HIF-1α-overexpressing tumor invasion and preventing tumor metastasis, and/or promoting tumor prophylaxis, using various types of inhibitors agai...
|
|
WO/2012/050390 |
The present application relates to a hydrogen production method using photosynthetic bacteria, comprising a step in which photosynthetic microorganisms are cultured under conditions under which photosynthesis takes place and in the prese...
|
|
WO/2012/050650 |
Materials and methods are described to produce xylitol from a mixture of hemicellulosic sugars by several routes. Examples include either as a direct co-product of a biorefinery or ethanol facility, or as a stand-alone product produced f...
|
|
WO/2012/049654 |
The present invention relates to novel mycobacterial compositions containing RNA and cell walls, and methods for making and using these compositions. These compositions have immune stimulating and anti-cancer activity. The present invent...
|
|
WO/2012/049306 |
The present invention relates to a method to induce alga and/or diatom cell bio-flocculation comprising inactivation of the expression of at least one photoreceptor in said alga and/or diatom, constructs able to inhibit the expression of...
|
|
WO/2012/048653 |
Provided in the present application is a recombinant long-life interferon fusion protein and use thereof, wherein the fusion protein consists of an N-terminal interferon and a C-terminal human albumin binding peptide as well as a glycine...
|
|
WO/2012/049179 |
The invention relates to a polypeptide having a mutation at one or more position corresponding to Y274 and/or D376 of SEQ ID NO: 51, wherein the polypeptide has at least 50% sequence identity with SEQ ID NO: 51, and wherein the polypepti...
|
|
WO/2012/049173 |
The invention relates to a polypeptide having a mutation at one or more position corresponding to T219 of SEQ ID NO: 55, wherein the polypeptide has at least 50% sequence identity with SEQ ID NO: 55, and wherein the polypeptide has perme...
|
|
WO/2012/049662 |
Hyperblebbing Salmonella strains are generated by disrupting one or more components of the Tol-Pal system, such as TolR. The blebs from these strains are useful immunogens for vaccination. The individual proteins found in these blebs can...
|
|
WO/2012/049170 |
The present invention relates to a yeast cell comprising one or more exogenous genes of a pentose metabolic pathway non-native to the yeast cell wherein the yeast cell has a disruption of the hxk1, hxk2 glk1 and gal1 native in the yeast ...
|
|
WO/2012/050221 |
The purpose of the present invention is to provide a method and device for culturing photosynthetic microorganisms using an upright transparent water tank that simply prevents the entry and breeding of microfauna such as Daphnia and Roti...
|
|
WO/2012/051210 |
Mesenchymal stem cells that selectively promote or suppress inflammation are provided, as well as methods of producing and using the same.
|
|
WO/2012/050125 |
The present invention provides a methodology for improving the yield of 2R,4R-monatin. Specifically, the present invention provides: a method for producing 2S,4R-monatin or a salt thereof, which comprises a process wherein 2S,4R-monatin ...
|
|
WO/2012/051431 |
Recombinant cells and methods are provided that relate to the use of isolated, engineered recombinant cells to directly or indirectly treat diseases or disorders in a mammalian host such as endocrine, gastrointestinal or autoimmune disor...
|
|
WO/2012/050220 |
The purpose of the present invention is to provide a method and device for culturing photosynthetic microorganisms using an upright transparent water tank that prevents the entry and breeding of microfauna such as Daphnia and Rotifera th...
|
|
WO/2012/051332 |
This specification relates to Formalin-fixed embedded quality control material for use for validation, verification, and to run controls for molecular assays. The quality control material can be used for a variety of tissues and for a va...
|
